Equity Analysts at RBC Capital Markets Maintain their “Outperform” rating for WH Smith PLC (LON:SMWH). The Target Price per Share is GBX 2300.00; Grandeur Peak Global Advisors Boosted By $701,500 Its Healthequity (HQY) Stake

WH Smith PLC (LON:SMWH) Logo

Grandeur Peak Global Advisors Llc increased Healthequity Inc (HQY) stake by 151.36% reported in 2017Q4 SEC filing. Grandeur Peak Global Advisors Llc acquired 15,250 shares as Healthequity Inc (HQY)’s stock rose 26.48%. The Grandeur Peak Global Advisors Llc holds 25,325 shares with $1.18 million value, up from 10,075 last quarter. Healthequity Inc now has $3.89 billion valuation. The stock increased 1.21% or $0.76 during the last trading session, reaching $63.83. About 251,804 shares traded. HealthEquity, Inc. (NASDAQ:HQY) has risen 49.52% since April 11, 2017 and is uptrending. It has outperformed by 37.97% the S&P500.

The firm have set target of GBX 2300.00 on WH Smith PLC (LON:SMWH) shares. This is 15.75% from the last price. In an analyst report shared with investors on Wednesday, 11 April, RBC Capital Markets kept their “Outperform” rating on shares of SMWH.

Grandeur Peak Global Advisors Llc decreased Staar Surgical Co (NASDAQ:STAA) stake by 108,269 shares to 327,766 valued at $5.08M in 2017Q4. It also reduced Dril (NYSE:DRQ) stake by 6,850 shares and now owns 45,400 shares. Genpact Ltd (NYSE:G) was reduced too.

Among 14 analysts covering HealthEquity Inc (NASDAQ:HQY), 12 have Buy rating, 0 Sell and 2 Hold. Therefore 86% are positive. HealthEquity Inc had 41 analyst reports since August 18, 2015 according to SRatingsIntel. The firm has “Buy” rating by Oppenheimer given on Monday, March 26. KeyBanc Capital Markets maintained it with “Buy” rating and $60.0 target in Tuesday, September 5 report. The rating was maintained by Robert W. Baird with “Hold” on Friday, November 3. The stock of HealthEquity, Inc. (NASDAQ:HQY) earned “Overweight” rating by KeyBanc Capital Markets on Thursday, April 5. On Tuesday, September 19 the stock rating was maintained by Robert W. Baird with “Hold”. On Tuesday, March 20 the stock rating was maintained by KeyBanc Capital Markets with “Overweight”. Chardan Capital Markets initiated the shares of HQY in report on Tuesday, December 13 with “Buy” rating. Robert W. Baird maintained HealthEquity, Inc. (NASDAQ:HQY) on Tuesday, March 20 with “Neutral” rating. The company was maintained on Wednesday, July 5 by Cantor Fitzgerald. The firm has “Buy” rating given on Wednesday, June 7 by Cantor Fitzgerald.

Among 16 analysts covering WH Smith (LON:SMWH), 5 have Buy rating, 1 Sell and 10 Hold. Therefore 31% are positive. WH Smith has GBX 2300 highest and GBX 1025 lowest target. GBX 1884.75’s average target is -5.29% below currents GBX 1990 stock price. WH Smith had 146 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of WH Smith PLC (LON:SMWH) earned “Hold” rating by Liberum Capital on Wednesday, June 8. On Thursday, October 12 the stock rating was maintained by Peel Hunt with “Hold”. The rating was maintained by Deutsche Bank on Friday, October 13 with “Hold”. Investec maintained the stock with “Buy” rating in Wednesday, January 20 report. The stock of WH Smith PLC (LON:SMWH) earned “Hold” rating by Liberum Capital on Wednesday, June 14. On Wednesday, January 20 the stock rating was maintained by Cantor Fitzgerald with “Hold”. The stock of WH Smith PLC (LON:SMWH) has “Equal Weight” rating given on Thursday, August 25 by Barclays Capital. RBC Capital Markets maintained WH Smith PLC (LON:SMWH) on Monday, February 8 with “Outperform” rating. The firm has “Buy” rating by Investec given on Friday, August 25. Investec maintained WH Smith PLC (LON:SMWH) on Thursday, August 20 with “Buy” rating.

HealthEquity, Inc. (NASDAQ:HQY) Ratings Chart